Clinical Trial Update: Pilot Study of Immunosuppression Drug Weaning in Liver Recipients Exhibiting Biomarkers of High Likelihood of Tolerance [NA]

View source ↗

Summary

A pilot trial evaluating weaning of immunosuppressive therapy in liver transplant recipients with biomarkers suggesting high tolerance was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Liver Transplantation | NA | Status: TERMINATED